ANI 製藥公司
DE ˙ DB ˙ US00182C1036
€54.50 0.00 (0.00%)
2023-08-21
分享價格
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership324,349 shares
Latest Disclosed Value $ 24,942,437
Invesco Ltd. reports 70.86% increase in ownership of BSFA / ANI Pharmaceuticals, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 324,349 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $24,942,437 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 189,836 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 70.86% during the quarter. The current value of the position is $17,677,020 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 324,349 134,513 70.86 24,942 66.45 0.0038
2026-02-19 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 189,836 39,178 26.00 14,986 8.59 0.0023
2025-11-13 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 150,658 -21,799 -12.64 13,800 22.64 0.0022
2025-08-13 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 172,457 -27,110 -13.58 11,253 -15.78 0.0019
2025-05-12 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 199,567 2,022 1.02 13,361 22.35 0.0025
2025-02-13 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 197,545 -22,814 -10.35 10,920 -16.93 0.0020
2024-11-12 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 220,359 -90,732 -29.17 13,147 -33.64 0.0025
2024-08-13 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 311,091 -12,951 -4.00 19,810 -11.57 0.0042
2024-05-14 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 324,042 65,596 25.38 22,401 57.20 0.0048
2024-02-13 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 258,446 -81,289 -23.93 14,251 -27.76 0.0034
2023-11-13 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 339,735 220,690 185.38 19,725 207.82 0.0053
2023-08-11 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 119,045 52,953 80.12 6,408 144.11 0.0017
2023-05-12 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 66,092 -6,385 -8.81 2,625 -9.95 0.0007
2023-02-13 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 72,477 6,603 10.02 2,916 37.69 0.0009
2022-11-14 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 65,874 -8,356 -11.26 2,117 -3.90 0.0007
2022-08-15 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 74,230 3,978 5.66 2,203 11.54 0.0007
2022-05-16 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 70,252 843 1.21 1,975 -38.26 0.0005
2022-02-14 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 69,409 -1,812 -2.54 3,199 36.83 0.0008
2021-11-15 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 71,221 -1,716 -2.35 2,338 -8.53 0.0006
2021-08-17 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 72,937 2,794 3.98 2,556 0.83 0.0006
2021-05-17 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 70,143 9,558 15.78 2,535 44.12 0.0007
2021-02-16 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 60,585 -13,659 -18.40 1,759 -16.00 0.0005
2020-11-16 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 74,244 -2,573 -3.35 2,094 -15.73 0.0007
2020-08-14 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 76,817 -189,279 -71.13 2,485 -77.08 0.0009
2020-05-15 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 266,096 -98,294 -26.97 10,841 -51.76 0.0046
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 364,390 162,577 80.56 22,472 52.78 0.0070
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 201,813 -12,427 -5.80 14,709 -16.48 0.0038
2019-08-14 2019-06-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 214,240 114,084 113.91 17,611 149.27 0.0045
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 214,240 114,084 17,611
2019-05-15 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 100,156 -14,300 -12.49 7,065 37.10 0.0024
2019-02-14 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 114,456 -59,627 -34.25 5,153 -47.65 0.0020
2018-11-14 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 174,083 53,519 44.39 9,843 22.21 0.0031
2018-08-14 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 120,564 79,020 190.21 8,054 232.95 0.0027
2018-05-15 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 41,544 -249,406 -85.72 2,419 -87.10 0.0009
2018-02-14 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 290,950 269,072 1,229.87 18,752 1,533.45 0.0068
2017-11-14 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 21,878 2,000 10.06 1,148 23.44 0.0004
2017-08-14 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 19,878 -109,385 -84.62 930 -85.47 0.0003
2017-05-15 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 129,263 -6,738 -4.95 6,400 -22.37 0.0021
2017-02-14 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 136,001 4,158 3.15 8,244 -5.76 0.0028
2016-11-14 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 131,843 -25,295 -16.10 8,748 -0.26 0.0030
2016-08-15 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 157,138 136,541 662.92 8,771 1,165.66 0.0032
2016-05-16 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 20,597 -6,133 -22.94 693 -42.54 0.0003
2016-02-16 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 26,730 1,753 7.02 1,206 22.19 0.0005
2015-11-16 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 24,977 3,279 15.11 987 -26.67 0.0004
2015-08-14 2015-06-30 13F ANI PHARMACEUTICALS INC COM COMMON 00182C103 21,698 -210,658 -90.66 1,346 -90.74 0.0005
2015-05-15 2015-03-31 13F ANI PHARMACEUTICALS INC COM COMMON 00182C103 232,356 223,148 2,423.41 14,534 2,695.00 0.0056
2015-02-13 2014-12-31 13F ANI PHARMACEUTICALS INC COM COMMON 00182C103 9,208 4,124 81.12 520 261.11 0.0002
2014-11-14 2014-09-30 13F ANI PHARMACEUTICALS INC COM COMMON 00182C103 5,084 218 4.48 144 -14.29 0.0001
2014-08-14 2014-06-30 13F ANI PHARMACEUTICALS INC COM COMMON 00182C103 4,866 4,866 168 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.